This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (5)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Psychiatry  • Attention Deficit Hyperactivity Disorder  • Tobacco  • Alert me on articles by topic

Bridget M. Kuehn

JAMA. 2006;295:483-484.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Physicians have long recognized that a disproportionate number of individuals with mental illnesses smoke. About 41% of all individuals who’ve had a mental illness in the past month smoke compared with 22.5% of those who have never had a mental illness (Lasser K et al. JAMA. 2000;284:2606-2610). Some estimates of smoking among the mentally ill are even higher and many studies show individuals with mental illnesses are less likely to quit. Now, scientists are beginning to understand the underlying causes of this discrepancy and their findings are pointing to potential new treatments for both mental illness and smoking cessation.

It turns out that individuals with schizophrenia, attention-deficit/hyperactivity disorder (ADHD), or other mental illnesses may experience more positive effects from smoking than do those without such disorders and such benefits may make them more vulnerable to initiating smoking and make them less likely to quit. Ongoing research . . . [Full Text of this Article]

SCHIZOPHRENIA TARGETED

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

How much do mental disorders contribute to New Zealand's tobacco epidemic?
Tobias et al.
Tobacco Control 2008;17:347-350.
ABSTRACT | FULL TEXT  

Cholinergic Agonists as Novel Treatments for Schizophrenia: The Promise of Rational Drug Development for Psychiatry
Lieberman et al.
Am. J. Psychiatry 2008;165:931-936.
FULL TEXT